Enhanced inflammatory responses have been suggested decades after radiation exposure in atomic-bomb survivors, but cellular and molecular alterations related to prolonged inflammation remain unclear. This study, utilizing longitudinal haematological data over 50 years for 14 000 persons, investigated whether radiation exposure promoted the relative increase in peripheral myeloid cells, known as an aging-associated indicator of lowgrade inflammation. Statistical modelling was performed with a linear mixed-effects model for leucocyte subsets, together with a proportional hazards regression model for all-cause mortality. We found that age trends in lymphocyte, neutrophil and monocyte percentages or counts differed before versus after age 60 years. Radiation dose was associated with monocyte percentages and counts, but not with the lymphoid-myeloid cell ratio. Radiation effects on monocytes were stronger after versus before age 60 years. Increases in monocyte percentages and counts were associated with higher risk of all-cause mortality. Studies of chromosomal aberrations have shown a clonal expansion of haematopoietic stem cells among atomic-bomb survivors. Therefore, radiation exposure might accelerate aging-associated clonal haematopoiesis, which could result in a long-lasting elevation of circulating monocytes.
Summary
Enhanced inflammatory responses have been suggested decades after radiation exposure in atomic-bomb survivors, but cellular and molecular alterations related to prolonged inflammation remain unclear. This study, utilizing longitudinal haematological data over 50 years for 14 000 persons, investigated whether radiation exposure promoted the relative increase in peripheral myeloid cells, known as an aging-associated indicator of lowgrade inflammation. Statistical modelling was performed with a linear mixed-effects model for leucocyte subsets, together with a proportional hazards regression model for all-cause mortality. We found that age trends in lymphocyte, neutrophil and monocyte percentages or counts differed before versus after age 60 years. Radiation dose was associated with monocyte percentages and counts, but not with the lymphoid-myeloid cell ratio. Radiation effects on monocytes were stronger after versus before age 60 years. Increases in monocyte percentages and counts were associated with higher risk of all-cause mortality. Studies of chromosomal aberrations have shown a clonal expansion of haematopoietic stem cells among atomic-bomb survivors. Therefore, radiation exposure might accelerate aging-associated clonal haematopoiesis, which could result in a long-lasting elevation of circulating monocytes.
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Inflammation is a host-defence response, typically to microbial infections or non-infectious tissue injury, that can become damaging and destructive when prolonged (Rea et al, 2018) . Chronic low-grade inflammation represents a universal characteristic of both human aging and age-related diseases, such as cancer and cardiovascular disease (Bektas et al, 2018 ). An enhanced inflammatory state has been observed among survivors of the atomic bombings of Hiroshima and Nagasaki (Neriishi et al, 2001; Hayashi et al, 2003; Hsu et al, 2010) : elevated levels of various inflammation markers [total leucocyte counts in the peripheral blood, erythrocyte sedimentation rates, plasma levels of C-reactive protein (CRP) and Interleukin-6 (IL6), serum levels of alpha-1 and 2 globulins, and sialic acid] were associated with radiation dose several decades after exposure. However, the cellular and molecular bases for radiation-associated chronic inflammation have not been defined.
Increases in total leucocyte counts and differential cell (lymphocyte, neutrophil and monocyte) counts have been associated with exposure to high-dose radiation (Neriishi et al, 2001; Hsu et al, 2010) . However, a more specific endpoint in blood measurements (e.g., the leucocyte subset percentage or the ratio of lymphocytes and myeloid cells) might more directly delineate the linkage among radiation dose, chronic inflammation and aging-related diseases in the survivors. Among the major leucocyte subsets, monocytes are a key inflammatory mediator, participating in inflammation through secretion of various cytokines and chemokines, and differentiating into long-lived macrophages. Given that leucocyte counts and their composition gradually change throughout human aging (Flegar-Mestric et al, 2000; Cheng et al, 2004) , this study analysed individual age-related changes in longitudinal leucocyte data over 50 years and tested the hypothesis that circulating monocytes increase in association with radiation dose. Furthermore, given that the differentiation potential of haematopoietic stem/progenitor cells (HSCs) biases to myeloid lineage cells with aging (Pang et al, 2011) as well as radiation exposure in mice (Chua et al, 2012; Shao et al, 2014) , we examined the ratio of peripheral lymphoid to myeloid cells to test the hypothesis that the myeloid bias of HSCs is promoted by radiation exposure.
Full blood counts (FBCs) -performed biannually since 1958 in the Adult Health Study (AHS) for 20 000 atomicbomb survivors (Kodama et al, 1996; Yamada et al, 2004 ) -provided longitudinal data on absolute numbers and percentages of each leucocyte subset in peripheral blood, which allowed us to quantify age-related haematological changes (from approximately 20-90 years) and to test our hypotheses regarding the impact of radiation exposure. A future study investigating how and to what extent radiation effects on the haematopoietic system contribute to the development of inflammatory diseases in radiation-exposed individuals should be planned, based on the robust data in longitudinal haematological and clinical observations.
Methods

Study design and participants
This study was a retrospective cohort study of Japanese atomic-bomb survivors who participated in the AHS at the Radiation Effects Research Foundation (RERF). The AHS includes survivors who were potentially exposed to atomicbomb radiation in either Hiroshima or Nagasaki, and residents of Hiroshima or Nagasaki who were not in either city at the time of the bombings in 1945. Health examinations in the AHS, including FBCs, have been conducted at outpatient clinics every 2 years since the cohort was established in 1958.
This analysis was limited to AHS participants who were enrolled in 1958 (original cohort) and 1977 (extension cohort) and contributed haematological data generated from FBCs until 2010 (n = 18 203). Because of the strong influence on haematological endpoints, participants with a history of any of following blood diseases either before or during the follow-up were excluded: leukaemia, myelodysplastic syndrome, malignant lymphoma, multiple myeloma, aplastic anaemia and other blood diseases [n = 227; see Table SI for International Classification of Diseases (ICD) codes]. Participants whose radiation dose was unknown (n = 1799), who did not have endpoint measurements available (n = 11), who had no information on smoking status or body mass index (BMI, n = 1813) and whose vital status was unknown (n = 4) were also excluded from the analysis. We also excluded measurement data with peripheral monocyte percentages >20% among leucocytes (198 observations) as potential outliers (the reference range for adults is 4-11% (Kratz et al, 2004) ). Selection procedures are summarized in Fig 1, and basic characteristics of the study participants are shown in Table I .
Outcomes, exposures, and covariates
In addition to absolute numbers and percentages of leucocyte subsets in the peripheral blood, the ratio of lymphocytes to monocytes and granulocytes was used to generate the lymphoid:myeloid (LM) ratio as an indicator for the myeloid bias of HSC differentiation potential. Vital status (alive or dead) of the study participants during the period 1958-2010 was ascertained based on mortality follow-up in the Life Span Study cohort of atomic-bomb survivors (Ozasa et al, 2012) . Revised Dosimetry System 2002 (DS02R1) weighted absorbed bone marrow doses, in units of gray (Gy), with a neutron weight of 10, were estimated from the Dosimetry System 2002 (DS02) (Cullings et al, 2017) . Demographic and clinical information included city of residence (Hiroshima or Nagasaki), exposure status (incity survivor or not-in-city resident), sex, age at exposure (equivalent to birth cohort because all survivors were exposed in 1945), age at measurement, smoking status, and BMI. Smoking information was obtained from questionnaires during AHS health examinations as well as mail surveys collected as part of the Life Span Study in 1965, 1969, 1978, 1991 and 2008 ; smoking status was updated over time and categorized as never, former, current or unknown. At RERF, FBC tests were conducted via microscopy until the early 1970s, and several different types of auto-analysers were used thereafter, depending on the city and examination period. Therefore, all models included indicator variables for the methods and auto-analysers used for FBC analysis.
This study was approved by the RERF Institutional Review Board, and was conducted according to the principles expressed in the Declaration of Helsinki. All participants provided written informed consent. 
Statistical analysis
Our analysis focused on estimating the associations of age and radiation exposure with longitudinal changes in haematological endpoints. Due to the lengthy follow-up of aging study participants, we sought to avoid the potential for bias that could arise from informative censoring of haematological endpoints due to death. For example, if a haematological endpoint was positively associated with mortality, study participants who remained alive would be expected to have lower values of that endpoint, which could lead to biased effect estimates. Therefore, for each haematological endpoint, we formulated a joint regression model that was composed of a linear mixed-effects model for the haematological endpoint and a proportional hazards regression model for the risk of all-cause mortality (Tsiatis et al, 1995; Wulfsohn & Tsiatis, 1997) . Participant-level random effects parameterized a dependence structure between haematological endpoints and survival times. Thus, covariate associations with haematological endpoints, covariate associations with mortality, and associations of haematological endpoints with mortality were estimated simultaneously.
Haematological endpoints were plotted as the median and 25th and 75th percentile within 2-year windows of age. These exploratory analyses suggested that longitudinal changes in haematological endpoints differed by sex before and after age 60 years. Therefore, the linear mixed-effects models estimated linear sex-specific trajectories before and after age 60 years and compared them using interaction terms. To explore radiation effects, residuals were calculated from adjusted models that did not include radiation dose, and plotted versus radiation dose. Based on these analyses, radiation effects were estimated by including a linear term for radiation dose. We also evaluated whether radiation effects differed before and after age 60 years using an interaction term with age. All models were adjusted for city of residence, exposure status, and their interaction, such that all zero-dose survivors were included in the reference group (French et al, 2017) . FBC analysis method, smoking status and BMI were included as time-dependent covariates. Participant-level random intercepts and random slopes for age quantified heterogeneity in trends across participants. All haematological endpoints exhibited a symmetric distribution, with the exception of the LM ratio, which was log transformed such that exponentiated regression coefficients represented percentage changes in the average LM ratio. Model diagnostics were based on subject-specific and population-averaged residuals.
For the proportional hazards regression model for all-cause mortality, participants were at risk from their age at entry into the AHS cohort until their age at exit due to death or censoring at the end of the study in 2010. The estimated haematological endpoint from the linear mixed-effects model was included as the primary exposure. Adjustment covariates included sex, the interaction between city of residence and exposure status, radiation dose and smoking status. The baseline hazard function was stratified by original versus extension AHS cohort and approximated using basis splines with unequal knots between strata. Model diagnostics were based on Martingale residuals. All analyses were performed with R 3.4.3 (R Foundation for Statistical Computing, Vienna, Austria), including the JM extension package (Rizopoulos, 2010) . Table I . Characteristics of the study cohort, presented as median (inter-quartile range) unless otherwise indicated as n (%).
In-city atomic bomb survivors Not-in-city residents Radiation dose* ≥1000 mGy Radiation dose* <1000 mGy n = 1616 n = 9393 n = 3340 
Results
A total of 14 349 participants met the inclusion criteria. Overall, the median follow-up time was 32.8 years (interquartile range, 20.6-47.8 years), during which data were collected at a median number of 10 health examinations (range, 1-27). There were 9552 deaths (66.6%). Demographic characteristics and the distributions of peripheral leucocyte subset numbers at baseline are shown in Table I . Compared to survivors exposed to radiation doses <1 Gy and unexposed not-in-city residents, survivors exposed to radiation doses ≥1 Gy were younger at exposure (P < 0.001) and were more likely to smoke (P < 0.001). There were no substantial differences in the distributions of peripheral leucocyte subset numbers at study entry. Figure 2 shows unadjusted age trends of lymphocyte, neutrophil and monocyte percentages among leucocytes; LM ratio (lymphocytes to neutrophils plus monocytes); and monocyte counts. For both men and women, unadjusted trends appeared to differ before and after age 60 years. Therefore, adjusted sex-specific trends were estimated and compared (Table II) . Age trends were significantly different before and after age 60 years for almost all haematological endpoints examined. Lymphocyte percentages among leucocytes remained constant among men and increased among women before age 60 years, but decreased after age 60 years among both men and women. In contrast, neutrophil percentages remained constant among men and decreased among women before age 60 years, but increased after age 60 years for both sexes. For monocyte percentages, there was a small but statistically significant increase after age 60 years among both men and women. As expected from these changes in cell percentages, the LM ratio decreased after age 60 years. Monocyte counts mainly decreased with aging; however, among women, monocyte counts began to increase after age 60 years.
We estimated adjusted associations between radiation exposure and haematological endpoints. There was no radiation association with lymphocyte percentage, neutrophil percentage or LM ratio (Table III) . However, we found significant increases in both the percentage and counts of monocytes with increasing radiation dose (Fig 3) . On average, each 1-Gy increase in weighted absorbed bone marrow dose was associated with a 0.06% increase in monocyte percentage and an increase in monocyte count of 0.009 9 10 9 /l (Table III) . Moreover, the association of radiation dose with monocyte levels was significantly stronger in blood samples taken after age 60 years versus before. For comparison, the mean monocyte count was 0.027 9 10 9 /l greater among current versus never smokers (95% confidence interval [CI]: 0.023, 0.03), whereas a 2-kg/m 2 increase in BMI was associated with an average increase of 0.009 9 10 9 monocytes/l (95% CI: 0.008, 0.01). [Correction added on 23 January 2019, after online publication: The mean monocyte count in the preceding line was corrected to 0.027 9 10 9 /l in this version]. Both of these associations were statistically significant (P < 0.001 for both). For monocyte percentages, the mean monocyte percentage was 0.04% lower among current versus never smokers (95% CI: À0.10, 0.01), whereas a 2-kg/ m 2 increase in BMI was associated with an average decrease of 0.007% (95% CI: À0.019, 0.004). Neither of these associations was statistically significant (P = 0.12 and P = 0.22, respectively). Model diagnostics did not indicate any systemic lack of fit. Finally, we examined adjusted relationships between leucocyte subsets and all-cause mortality, and found all the endpoints were significantly associated with mortality (Table IV) . Increased monocyte percentages and counts, increased neutrophil percentages, decreased lymphocyte percentages, and decreased LM ratios were associated with an increased risk of all-cause mortality. Model diagnostics did not indicate any systemic lack of fit.
Discussion
While previous studies have shown that various inflammatory markers were elevated in association with past radiation exposure as well as individual aging in atomic-bomb survivors (Neriishi et al, 2001; Hayashi et al, 2003; Hsu et al, 2010) , how inflammation manifests through radiation-associated alterations in the haematopoietic system remains unclear. In this large-scale longitudinal study, we delineated aging-related changes in leucocyte subset percentages, counts, and the LM ratio during human aging. Compared with the previous study (Hsu et al, 2010) , the sample size and the follow-up period of the present study are larger and longer, respectively. This allowed us to examine aging effects more comprehensively, as well as to determine how age impacts radiation associations with haematological endpoints. Also, haematological endpoints are different between the previous report and this study: we examined leucocyte subset percentages and ratios in addition to the counts. Moreover, the statistical methods are different: this study used modern joint regression models to account for the potential bias that could arise from informative censoring of haematological endpoints due to death. The age trends observed in our study, including different patterns before and after 60 years of age, are comparable with previous reports (Flegar-Mestric et al, 2000; Cheng et al, 2004) . In particular, our results are consistent with a recent cross-sectional study that examined peripheral leucocytes in an Asian population (Chen et al, 2016) and found that lymphocyte percentages were higher and neutrophil percentages were lower among men compared to women before age 60 years, but were reversed thereafter. These age-sex patterns could be largely due to sex hormone levels, as suggested by several studies (Bain & England, 1975; Medina et al, 2000; Molloy et al, 2003; Perez-de-Heredia et al, 2015) . For example, higher oestradiol levels, usually observed in premenopausal women (Gubbels Bupp, 2015) , have been shown to delay neutrophil apoptosis but suppress B-lymphocyte Unadjusted age trends of peripheral leucocyte subsets. Unadjusted age trends of haematological endpoints are plotted as the median (line) and 25th and 75th percentile (shaded region) within 2-year windows of age. There were 601 participants who contributed data at ages <20 years and 288 participants who contributed data at ages ≥90 years. The figures were truncated at these timepoints because the relatively small numbers of participants resulted in large uncertainty in the summaries presented.
Prolonged Monocytosis in Radiation-Exposed People ª 2019 British Society for Haematology and John Wiley & Sons Ltd production in the bone marrow. Declining lymphocyte percentages after the age of 60 years in both sexes can be largely ascribed to both the myeloid bias of HSC differentiation potential (Pang et al, 2011) and decrease in thymic T-cell production in aging individuals. Consistent with a recent report (Chen et al, 2016) , immunological aging, as it appears in the proportion of peripheral leucocytes, might become apparent at the age of around 60 years. A previous study on the atomic-bomb survivor population (Hsu et al, 2010) detected weak associations of radiation exposure with peripheral lymphocyte or neutrophil counts, but a stronger association with monocyte counts. In this study, increases in monocyte percentages and counts were apparent over a prolonged time after radiation exposure, although the radiation-associated change was rather small (e.g., monocyte counts increased by 0.009 9 10 9 /l per Gy of radiation dose; the median monocyte count was 0.39 9 10 9 /l at baseline). On the other hand, a prospective cohort study (Rogacev et al, 2011) showed that the hazard ratio of incident cardiovascular diseases was 1.26 for an increase of 0.01 monocytes (CD14 ++ CD16 + cells) 9 10 9 /l. The counts of peripheral monocytes and neutrophils have been demonstrated to predict cardiovascular disease risks (Pinto et al, 2004; Ruggiero et al, 2007; Davis et al, 2016) . Therefore, there is a possibility that a persistently higher level of monocytes over a prolonged time period might increase the likelihood of developing inflammatory diseases (Kusunoki & Hayashi, 2008) . Alternatively, it is also possible that disease itself or its therapy may be partly responsible for the increases in peripheral monocytes. Indeed, myeloid and lymphoid malignancies, myocardial infarction and solid tumours are listed as potential causes of peripheral monocytosis (Lynch et al, 2018) , and risks of haematological malignancies and solid tumours are increased among atomicbomb survivors (Ozasa et al, 2012) . In this study, however, the association between radiation exposure and monocytosis was observed after exclusion of participants diagnosed with haematological diseases. A similar association was reported in the previous study (Hsu et al, 2010) , in which haematological data analyses were conducted with adjustment of inflammatory diseases including solid tumours. Therefore, any effect of disease or therapy on the monocyte count would not significantly confound the association between radiation exposure and 
<0.001
CI, confidence interval. *Adjusted for city of residence, exposure status, DS02R1 weighted absorbed bone marrow dose, Adult Health Study cohort, full blood count analysis method, smoking status, and body mass index. †P value for evaluating the null hypothesis of equality in the age trend before and after age 60 years. monocytosis. Nonetheless, we only considered selected blood diseases as exclusion criteria, which is a limitation in this study. Further investigation considering inflammatory diseases, such as cancer, cardiovascular disease, obesity, and diabetes, might prove that the monocyte count is a pathogenic risk marker for a particular disease. Given the limited lifespan of mature monocytes and their precursors, and given many years that have elapsed after radiation exposure, long-term HSCs in the exposed bone marrow would be particularly involved in radiation-associated monocyte increase. However, there was no association between radiation dose and the LM ratio in this study, suggesting that the myeloid bias of HSCs might not be promoted by radiation exposure. Recent studies indicate that clonal expansion of HSCs -clonal haematopoiesis -accompanies a slight increase in monocyte counts but not in the lymphoid-granulocyte ratio Coombs et al, 2017; Zink et al, 2017) . Clonal haematopoiesis is strongly associated with human aging (the prevalence is less than 0.5% in persons before 35 years of age, but is more than 25% after the age of 65 years, with recurrent somatic mutations typically in the DNMT3A, TET2, and ASXL1 genes (Jaiswal et al, 2014; Zink et al, 2017) ), but it is also associated with a history of radiotherapy in non-haematological cancer patients (Coombs et al, 2017) . Notably, clonal chromosomal aberrations were frequently observed in heavily-exposed (>1 Gy) atomic-bomb survivors, and some clonal cases might originate from mutated HSCs (Nakano et al, 2004) . In mousemodel studies, deletion of Tet2 in HSCs was shown to alter their differentiation toward monocytic lineages and monocytosis in peripheral blood (Li et al, 2011) . Taken together, it is conceivable that aging-related clonal haematopoiesis is somehow accelerated by radiation exposure, possibly through cell killing and/or somatic mutations in DNMT3A, TET2, etc., in HSCs, resulting in a life-long monocyte increase among atomic-bomb survivors. Although the follow-up period and the number of participants were quite different from our study, Rotman et al (1977) showed, over 40 years ago, an increase in circulating monocytes at 3 weeks after radiotherapy and discussed an indirect effect of radiation on the bone marrow because they observed no difference in monocyte increase between irradiated regions (pelvic vs thorax: there is twice as much marrow in the pelvic region). HSCs and niche cells in the bone marrow as well as circulating monocytes express receptors, such as Toll-like receptor 4, that are triggered by danger signals from damaged tissues or metabolic abnormality to induce HSC proliferation and myeloid differentiation (Dutta & Nahrendorf, 2014; Murphy et al, 2014; Nahrendorf, 2018) . In atomic-bomb survivors, some tissue damage might remain long after radiation exposure, and serum cholesterol levels were elevated (Wong et al, 1999) . In addition to the evolving hypothesis for clonal haematopoiesis and radiation exposure, therefore, we postulate that radiation exposure induced signal molecules priming HSCs to produce a somewhat higher than normal level of monocytes over a prolonged time. 
